Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

7.76
Delayed Data
As of Aug 28
 +0.25 / +3.33%
Today’s Change
6.71
Today|||52-Week Range
16.87
-36.65%
Year-to-Date

Today’s Trading

Previous close7.51
Today’s open7.45
Day’s range7.43 - 7.82
Volume2,382,829
Average volume (3 months)2,619,578
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-11.11%
Earnings growth (this year)+50.71%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.60

Competitors

 Today’s
change
Today’s
% change
RPTPRaptor Pharmaceutica...+0.16+1.26%
TXMDTherapeuticsMD Inc+0.17+2.85%
ZFGNZafgen Inc+0.36+0.98%
RGENRepligen Corp-0.09-0.26%
Data as of 4:00pm ET, 08/28/2015

Financials

Next reporting dateNovember 10, 2015
EPS forecast (this quarter)$0.04
Annual revenue (last year)$0.00
Annual profit (last year)-$69.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Secretary, EVP &
Investor Relations Contact
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts

Partner Offers